NCT07429487Recruiting
Assessment of Adherence to Remotely Monitored Physical Activity Tracked on a Smartwatch, and Its Impact on Reducing Fatigue 3 Months After Adjuvant Chemotherapy for Cancer
Source: ClinicalTrials.gov · Last updated 15 Sept 2026
Brief summary (registry, in English)
A single-center, randomized (1:1) open-label, prospective, stratified study with two parallel arms, designed to evaluate adherence to the adapted physical activity (APA) program for patients participating in an APA program and to compare changes in fatigue at 3 months in patients who have completed adjuvant systemic chemotherapy for cancer and are participating in an APA program.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 98 (estimated)
- First submitted
- 9 Feb 2026
- Start date
- 15 Sept 2026
- Primary completion date
- 15 Sept 2029
- Lead sponsor
- Centre Antoine Lacassagne
- Diseases
- Pancreatic cancer, Colorectal cancer, Ovarian cancer
- NCT number
- NCT07429487
What you commit to
- Study type: Interventional
- Planned participants: 98
- From 15 Sept 2026 to the primary completion date, 15 Sept 2029
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patient who has received adjuvant immunotherapy,
Other illness
- New cancer treatment planned (excluding hormone therapy),
- Decompensated or unstable chronic conditions
- Chronic respiratory failure requiring long-term O2 therapy
- Diabetes with plantar ulceration
Other
- Cardiological contraindication to the program
- Severe malnutrition
- Rheumatological unfitness as determined by the oncologist,
- Progressive or chronic non-healing bedsore/wound
- Recent unhealed fracture
- Patient participating in another interventional clinical study at the time of signing the informed consent form.
- Vulnerable persons as defined in Articles L1121-5 to -8
Who the study is looking for
- Patients aged 18 to 75 years old,
- Histologically proven non-metastatic adenocarcinoma of breast, colorectal, ovarian, pancreatic, biliary, or gastric origin,
- Adjuvant chemotherapy completed less than 3 months ago (excluding hormone therapy),
- PS 0 or 1 according to the World Health Organization (WHO) scale,
- No recurrence since the end of adjuvant chemotherapy,
- Patient who has voluntarily agreed to participate in the study and sign the written informed consent form,
- Patient affiliated with a Social Security scheme.
Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Centre Antoine Lacassagne Coordinator of this site? Confirm its status | Nice | France | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.